search
Back to results

An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Primary Purpose

Atopic Dermatitis

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
RPT193
Placebo
Sponsored by
RAPT Therapeutics, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atopic Dermatitis focused on measuring atopic dermatitis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinically confirmed diagnosis of active atopic dermatitis (AD), according to the revised Hanifin and Rajka criteria
  • 12-month history of AD and had no significant flares in AD for at least 4 weeks before screening
  • inadequate response to a ≥1 month treatment with topical medications
  • Atopic dermatitis covering ≥10% of the body surface area
  • EASI score ≥16
  • Validated Investigator Global Assessment (VIGA) ≥3
  • Use of emollient(s) at least 2x daily for 1 week prior to baseline
  • Negative coronavirus disease (COVID)-19 results at screening

Exclusion Criteria:

  • Uncontrolled moderate-to-severe asthma
  • Uncontrolled diabetes
  • Stage III or IV cardiac failure
  • Severe renal condition
  • Major surgery within 8 weeks of screening
  • Immunodeficiency and/or receipt of immunosuppressive drugs within 4 weeks of baseline
  • Use of systemic Janus kinase (JAK) inhibitor within 8 weeks of baseline
  • Received live or live-attenuated vaccine within 4 weeks of baseline
  • Prior receipt of RPT193

Sites / Locations

  • Cahaba Dermatology and Skin Health CenterRecruiting
  • Perseverance Research CenterRecruiting
  • Arkansas Research Trials, LLCRecruiting
  • California Dermatology & Clinical Research InstituteRecruiting
  • First OC DermatologyRecruiting
  • Grimes CenterRecruiting
  • Dermatology Research AssociatesRecruiting
  • Wallace Medical GroupRecruiting
  • Velocity Clinical ResearchRecruiting
  • Integrative Skin Science and ResearchRecruiting
  • Clinical Science InstituteRecruiting
  • Clinical Trials Research InstituteRecruiting
  • Foxhall Research CenterRecruiting
  • Driven Research LLCRecruiting
  • Florida Academic Centers Research and Education, LLCRecruiting
  • Palm Beach Dermatology GroupRecruiting
  • Lenus Research & Medical Group, LLCRecruiting
  • Forcare Clinical ResearchRecruiting
  • Skin Care Physicians of GeorgiaRecruiting
  • Marietta Dermatology Clinical Research, Inc.Recruiting
  • Georgia Skin & Cancer ClinicRecruiting
  • University Dermatology and Vein ClinicRecruiting
  • Dawes Fretzin Clinical Research Group, LLCRecruiting
  • The Indiana Clinical Trials Center PCRecruiting
  • Skin Sciences PLLCRecruiting
  • DelRicht ResearchRecruiting
  • Schweiger Dermatology Group, PC Research DivisionRecruiting
  • MetroBoston Clinical PartnersRecruiting
  • Beacon Clinical Research, LLCRecruiting
  • Fivenson DermatologyRecruiting
  • St. Joseph Dermatology and Vein ClinicRecruiting
  • Medisearch Clinical TrialsRecruiting
  • Advanced Dermatology of the MidlandsRecruiting
  • Skin Specialists PC (Schlessinger MD)Recruiting
  • Schweiger Dermatology GroupRecruiting
  • Forest Hills Dermatology GroupRecruiting
  • JUVA Skin & Laser CenterRecruiting
  • Ichan School of Medicine at Mount SinaiRecruiting
  • Markowitz Medical, PLLCRecruiting
  • Apex Clinical Research CenterRecruiting
  • Health ConceptsRecruiting
  • DermResearchRecruiting
  • Studies in Dermatology, LLCRecruiting
  • Dermatology Treatment and Research CenterRecruiting
  • Progressive Clinical ResearchRecruiting
  • Acclaim DermatologyRecruiting
  • Jordan Valley Dermatology CenterRecruiting
  • West End Dermatology AssociatesRecruiting
  • Dermatology Associates of Seattle
  • Premier Clinical ResearchRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

RPT193 400 mg

RPT193 200 mg

RPT193 50 mg

Placebo

Arm Description

RPT193 400 mg oral tablet administered daily for 16 weeks

RPT193 200 mg oral tablet administered daily for 16 weeks

RPT193 50 mg oral tablet administered daily for 16 weeks

Matching placebo oral tablet administered daily for 16 weeks

Outcomes

Primary Outcome Measures

Clinical efficacy
% change in Eczema Area Severity Index (EASI)
Safety as measured by adverse events
Incidence of treatment-emergent adverse events

Secondary Outcome Measures

Full Information

First Posted
May 26, 2022
Last Updated
May 31, 2023
Sponsor
RAPT Therapeutics, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05399368
Brief Title
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Official Title
A Phase 2 Study to Evaluate the Efficacy and Safety of RPT193 as Monotherapy in Adults With Moderate-to-Severe Atopic Dermatitis
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 7, 2022 (Actual)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
RAPT Therapeutics, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Phase 2 study of RPT193 in adults with atopic dermatitis
Detailed Description
Randomized, placebo-controlled Phase 2 study of RPT193 in adults with moderate-to-severe atopic dermatitis

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atopic Dermatitis
Keywords
atopic dermatitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Double blind
Allocation
Randomized
Enrollment
268 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
RPT193 400 mg
Arm Type
Experimental
Arm Description
RPT193 400 mg oral tablet administered daily for 16 weeks
Arm Title
RPT193 200 mg
Arm Type
Experimental
Arm Description
RPT193 200 mg oral tablet administered daily for 16 weeks
Arm Title
RPT193 50 mg
Arm Type
Experimental
Arm Description
RPT193 50 mg oral tablet administered daily for 16 weeks
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Matching placebo oral tablet administered daily for 16 weeks
Intervention Type
Drug
Intervention Name(s)
RPT193
Intervention Description
RPT193 is an antagonist of the C-C motif chemokine receptor 4 (CCR4) that inhibits CCR4-mediated chemotaxis toward both CCL22 and CCL17
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Nonactive placebo tablet
Primary Outcome Measure Information:
Title
Clinical efficacy
Description
% change in Eczema Area Severity Index (EASI)
Time Frame
16 weeks
Title
Safety as measured by adverse events
Description
Incidence of treatment-emergent adverse events
Time Frame
16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinically confirmed diagnosis of active atopic dermatitis (AD), according to the revised Hanifin and Rajka criteria 12-month history of AD and had no significant flares in AD for at least 4 weeks before screening inadequate response to a ≥1 month treatment with topical medications Atopic dermatitis covering ≥10% of the body surface area EASI score ≥16 Validated Investigator Global Assessment (VIGA) ≥3 Use of emollient(s) at least 2x daily for 1 week prior to baseline Negative coronavirus disease (COVID)-19 results at screening Exclusion Criteria: Uncontrolled moderate-to-severe asthma Uncontrolled diabetes Stage III or IV cardiac failure Severe renal condition Major surgery within 8 weeks of screening Immunodeficiency and/or receipt of immunosuppressive drugs within 4 weeks of baseline Use of systemic Janus kinase (JAK) inhibitor within 8 weeks of baseline Received live or live-attenuated vaccine within 4 weeks of baseline Prior receipt of RPT193
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Trial Manager
Phone
650-489-9000
Email
clinical.trials@rapt.com
Facility Information:
Facility Name
Cahaba Dermatology and Skin Health Center
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35244
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Perry
Phone
205-778-1564
Email
jennifer@vialtrials.com
Facility Name
Perseverance Research Center
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85254
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brandon McCravey
Phone
480-471-6132
Email
bmccravey@prcresearcheducation.com
Facility Name
Arkansas Research Trials, LLC
City
North Little Rock
State/Province
Arkansas
ZIP/Postal Code
72117
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jimmy Tutton
Phone
501-621-1100
Email
jtutton@arkansasresearchtrials.com
Facility Name
California Dermatology & Clinical Research Institute
City
Encinitas
State/Province
California
ZIP/Postal Code
92024
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Annie Owens
Phone
760-203-3839
Ext
103
Email
AOwens@cdcrinstitute.com
Facility Name
First OC Dermatology
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vanessa Montanez
Phone
714-531-2966
Email
vanessa.firstocdermatology@gmail.com
Facility Name
Grimes Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90036
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shanaya Dias
Phone
323-467-4389
Email
shanaya@vialtrials.com
Facility Name
Dermatology Research Associates
City
Los Angeles
State/Province
California
ZIP/Postal Code
90045
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Mannas
Phone
310-337-7171
Email
lmannas@drsofen.com
Facility Name
Wallace Medical Group
City
Los Angeles
State/Province
California
ZIP/Postal Code
90056
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
JACKIE BRAL, MD ACRP
Phone
310-777-0405
Email
jmorenobral@sbcglobal.net
Facility Name
Velocity Clinical Research
City
North Hollywood
State/Province
California
ZIP/Postal Code
91606
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sana Ijaz
Phone
818-558-7555
Email
sijaz@velocityclinical.com
Facility Name
Integrative Skin Science and Research
City
Sacramento
State/Province
California
ZIP/Postal Code
95815
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Waqas Burney
Phone
916-524-1216
Email
waqas@integrativeskinresearch.com
Facility Name
Clinical Science Institute
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carolyn Ferguson
Phone
310-828-8887
Email
cferguson@csird.com
Facility Name
Clinical Trials Research Institute
City
Thousand Oaks
State/Province
California
ZIP/Postal Code
91320
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shawn Ahoubim
Phone
805-298-7021
Email
clinicaltrials@calderm.net
Facility Name
Foxhall Research Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20016
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eva Tickle
Phone
202-695-1000
Email
etickle@mydermgroup.com
Facility Name
Driven Research LLC
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Victor Gisbert
Phone
305-677-2275
Email
vgisbert@drivenclinicalresearch.com
Facility Name
Florida Academic Centers Research and Education, LLC
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fabio Azevedo
Phone
305-785-7452
Email
fazevedo@fadcresearch.com
Facility Name
Palm Beach Dermatology Group
City
Delray Beach
State/Province
Florida
ZIP/Postal Code
33484
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shameika Park
Phone
561-559-1516
Email
shameika@vialtrials.com
Facility Name
Lenus Research & Medical Group, LLC
City
Sweetwater
State/Province
Florida
ZIP/Postal Code
33172
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yelenia Reyno
Phone
305-592-4692
Email
yreyno@lenusresearch.com
Facility Name
Forcare Clinical Research
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amanda Gonzalez
Phone
813-264-2155
Email
agonzalez@cenexel.com
Facility Name
Skin Care Physicians of Georgia
City
Macon
State/Province
Georgia
ZIP/Postal Code
31217
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Smith
Phone
478-742-2180
Ext
258
Email
jennifer@vialtrials.com
Facility Name
Marietta Dermatology Clinical Research, Inc.
City
Marietta
State/Province
Georgia
ZIP/Postal Code
30060
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
April Brown
Phone
770-422-1013
Email
abrown@mdcrinc.com
Facility Name
Georgia Skin & Cancer Clinic
City
Savannah
State/Province
Georgia
ZIP/Postal Code
31419
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tiffany Tucker
Email
tiffany.tucker@elligodirect.com
Facility Name
University Dermatology and Vein Clinic
City
Darien
State/Province
Illinois
ZIP/Postal Code
60561
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lider Koc
Phone
312-404-9135
Email
liderudr@gmail.com
Facility Name
Dawes Fretzin Clinical Research Group, LLC
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46250
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley Wallace
Phone
317-516-5030
Ext
102
Email
awallace@ecommunity.com
Facility Name
The Indiana Clinical Trials Center PC
City
Plainfield
State/Province
Indiana
ZIP/Postal Code
46168
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nikki Mosley
Phone
317-837-6082
Email
nmosley@indianatrials.com
Facility Name
Skin Sciences PLLC
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40217'
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christina Stewart
Phone
502-451-9000
Email
wedoderm@yahoo.com
Facility Name
DelRicht Research
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70809
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hilary Kingsley
Phone
504-336-2667
Email
hkingsley@delricht.com
Facility Name
Schweiger Dermatology Group, PC Research Division
City
Columbia
State/Province
Maryland
ZIP/Postal Code
21044
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Diana Aranzazu
Phone
201-951-0701
Email
diana.aranzazu@schweigerderm.com
Facility Name
MetroBoston Clinical Partners
City
Brighton
State/Province
Massachusetts
ZIP/Postal Code
02135
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stella Schandoff
Phone
781-444-0900
Email
stellaschandy@yahoo.com
Facility Name
Beacon Clinical Research, LLC
City
Quincy
State/Province
Massachusetts
ZIP/Postal Code
02169
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katsue Seki
Phone
774-462-6610
Email
katsue@beaconclinical.com
Facility Name
Fivenson Dermatology
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48103
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Fader
Phone
734-222-9630
Email
lfader@fivensondermatology.com
Facility Name
St. Joseph Dermatology and Vein Clinic
City
Saint Joseph
State/Province
Michigan
ZIP/Postal Code
49085
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lider Koc
Phone
312-404-9135
Email
liderkoc@gmail.com
Facility Name
Medisearch Clinical Trials
City
Saint Joseph
State/Province
Missouri
ZIP/Postal Code
64506
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
April Gibson
Phone
816-364-1515
Email
April.Gibson@medisearchderma.com
Facility Name
Advanced Dermatology of the Midlands
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68144
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julie Sigmund
Phone
402-905-3640
Email
julie.sigmund@midlandsderm.com
Facility Name
Skin Specialists PC (Schlessinger MD)
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68144
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kayleigh Koziol
Phone
402-697-6599
Email
Kayleigh@lovelyskin.com
Facility Name
Schweiger Dermatology Group
City
Verona
State/Province
New Jersey
ZIP/Postal Code
07044
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Malgorzata Lasocha
Phone
973-571-2121
Ext
5892
Email
malgorzata.lasocha@schweigerderm.com
Facility Name
Forest Hills Dermatology Group
City
Kew Gardens
State/Province
New York
ZIP/Postal Code
11415
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tazrin Tripti
Phone
718-459-0900
Email
mtripti@aol.com
Facility Name
JUVA Skin & Laser Center
City
New York
State/Province
New York
ZIP/Postal Code
10022
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mithun Mishu
Phone
212-421-9501
Email
mithunm@juvaskin.com
Facility Name
Ichan School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Giselle Singer
Phone
212-241-3288
Email
giselle.singer@mssm.edu
Facility Name
Markowitz Medical, PLLC
City
New York
State/Province
New York
ZIP/Postal Code
10128
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dimitri Vermes
Phone
212-838-3120
Email
dimitri@OptiSkinMedical.com
Facility Name
Apex Clinical Research Center
City
Mayfield Heights
State/Province
Ohio
ZIP/Postal Code
44124
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Teresa Hanslik
Phone
440-477-1570
Email
thanslik@mindspring.com
Facility Name
Health Concepts
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57702
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marty Beasley
Phone
605-390-7600
Email
mbeasley@rchealthconcepts.com
Facility Name
DermResearch
City
Austin
State/Province
Texas
ZIP/Postal Code
78759
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rebecca Rodriguez
Phone
512-349-9889
Email
rebecca@vialtrials.com
Facility Name
Studies in Dermatology, LLC
City
Cypress
State/Province
Texas
ZIP/Postal Code
77433
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lilia Garcia
Phone
281-377-6665
Email
lgarcia@studiesindermatology.com
Facility Name
Dermatology Treatment and Research Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alba Quinones
Phone
469-754-1585
Email
aquinones@dermcaremgt.com
Facility Name
Progressive Clinical Research
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78213
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amber Rogers, BSN, RN
Phone
210-614-5557
Email
arogers@progclin.com
Facility Name
Acclaim Dermatology
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77479
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shailynn Cruz
Phone
832-770-6388
Email
shailynn@vialtrials.com
Facility Name
Jordan Valley Dermatology Center
City
South Jordan
State/Province
Utah
ZIP/Postal Code
84095
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Phil Ribeiro
Phone
801-316-0266
Email
pribeiro@jvderm.com
Facility Name
West End Dermatology Associates
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23233
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adrian F Knight
Phone
804-249-2111
Email
adrianknight@dominionmedicalinc.com
Facility Name
Dermatology Associates of Seattle
City
Seattle
State/Province
Washington
ZIP/Postal Code
98101
Country
United States
Individual Site Status
Withdrawn
Facility Name
Premier Clinical Research
City
Spokane
State/Province
Washington
ZIP/Postal Code
99202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kay Haskins
Phone
509-343-3710
Email
khaskins@premierclinicalresearch.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

We'll reach out to this number within 24 hrs